Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Lane

Showing results (121-130 of 235) with videos related to

Pageof 24
Sort By:
Oncotarget|February 15, 2011
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapyBhavya Rao, Ingeborg M M van Leeuwen, Maureen Higgins, et al.
Oncogene|February 13, 2018
p53 isoforms regulate premature aging in human cellsNatalia von Muhlinen, Izumi Horikawa, Fatima Alam, et al.
Nanomaterials (Basel, Switzerland)|April 25, 2020
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized LipodisksSara Lundsten, Víctor Agmo Hernández, Lars Gedda, et al.
Scientific Reports|December 17, 2013
Rational optimization of conformational effects induced by hydrocarbon staples in peptides and their binding interfacesDilraj Lama, Soo T Quah, Chandra S Verma, et al.
Cell Cycle (Georgetown, Tex.)|May 12, 2011
NPMc(+) AML cell line shows differential protein expression and lower sensitivity to DNA-damaging and p53-inducing anticancer compoundsQiao Jing Lew, Chuan Hao Tan, Meera Gurumurthy, et al.
Journal of Chemical Information and Modeling|May 30, 2019
Characterization of Hydration Properties in Structural Ensembles of BiomoleculesMohan R Pradhan, Minh N Nguyen, Srinivasaraghavan Kannan, et al.
Journal of Molecular Biology|November 10, 2009
Rational design and biophysical characterization of thioredoxin-based aptamers: insights into peptide graftingChristopher J Brown, Shubhra Ghosh Dastidar, Hai Yun See, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2008
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatinKelly A Avery-Kiejda, Xu Dong Zhang, Luke J Adams, et al.
Cancer Research|June 17, 2005
Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1David E MacCallum, Jean Melville, Sheelagh Frame, et al.
Cell Cycle (Georgetown, Tex.)|May 28, 2010
Detection of the 113p53 protein isoform: a p53-induced protein that feeds back on the p53 pathway to modulate the p53 response in zebrafishLin Guo, Joy Chua, Danesh Vijayakumar, et al.
Pageof 24

Showing results (121-130 of 235) with videos related to

Sort By:
Pageof 24
Oncotarget|February 15, 2011
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapyBhavya Rao, Ingeborg M M van Leeuwen, Maureen Higgins, et al.
Oncogene|February 13, 2018
p53 isoforms regulate premature aging in human cellsNatalia von Muhlinen, Izumi Horikawa, Fatima Alam, et al.
Nanomaterials (Basel, Switzerland)|April 25, 2020
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized LipodisksSara Lundsten, Víctor Agmo Hernández, Lars Gedda, et al.
Scientific Reports|December 17, 2013
Rational optimization of conformational effects induced by hydrocarbon staples in peptides and their binding interfacesDilraj Lama, Soo T Quah, Chandra S Verma, et al.
Cell Cycle (Georgetown, Tex.)|May 12, 2011
NPMc(+) AML cell line shows differential protein expression and lower sensitivity to DNA-damaging and p53-inducing anticancer compoundsQiao Jing Lew, Chuan Hao Tan, Meera Gurumurthy, et al.
Journal of Chemical Information and Modeling|May 30, 2019
Characterization of Hydration Properties in Structural Ensembles of BiomoleculesMohan R Pradhan, Minh N Nguyen, Srinivasaraghavan Kannan, et al.
Journal of Molecular Biology|November 10, 2009
Rational design and biophysical characterization of thioredoxin-based aptamers: insights into peptide graftingChristopher J Brown, Shubhra Ghosh Dastidar, Hai Yun See, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2008
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatinKelly A Avery-Kiejda, Xu Dong Zhang, Luke J Adams, et al.
Cancer Research|June 17, 2005
Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1David E MacCallum, Jean Melville, Sheelagh Frame, et al.
Cell Cycle (Georgetown, Tex.)|May 28, 2010
Detection of the 113p53 protein isoform: a p53-induced protein that feeds back on the p53 pathway to modulate the p53 response in zebrafishLin Guo, Joy Chua, Danesh Vijayakumar, et al.
Pageof 24